MEIRAGTX UK II LIMITED

1. MEIRAGTX UK II LIMITED 2016-06-25 → present
2. ATHENA VISION LIMITED 2014-12-10 → 2016-06-25

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Accounting basis

FRS 102

Reporting scope

Standalone (parent only)

Auditor

Ernst & Young LLP

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“Based on the directors consideration of the forecast cash requirements of the Company and the ability of the ultimate parent company, MeiraGTx Holdings plc, to provide financial support to the Company to meet its liabilities as and when they fall due for a period of 12 months from the approval of these financial statements, the directors continue to adopt the going concern basis in preparing the annual financial statements.”

Group structure

1. MEIRAGTX UK II LIMITED · parent
   1. MeiraGTx Netherland B.V.1 100% · Netherlands · Biomedical research
   2. MeiraGTx B.V.1 100% · Netherlands · Biomedical research
   3. MeiraGTx Belgium BV2 100% · Belgium · Clinical trial support services

Significant events

• “Following an internal restructure on the 25 June 2025, MeiraGTx Netherland B.V, MeiraGTx B.V and MeiraGTx Belgium BV ceased to be subsidiary undertakings of the Company with ownership transferred to the Company's indirect parent MeiraGTx Limited and the Company's immediate parent became MeiraGTx Manufacturing Limited.”
• “On 9 March 2025, the Group entered into a strategic collaboration with Hologen Limited, a non-cellular company limited by shares incorporated in Guernsey ("Hologen"), and its affiliates.”
• “On 15 April 2026, the Company entered into a Termination Agreement, terminating the Asset Purchase Agreement entered into with Janssen on 20 December 2023.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

8

last 12 months

Capital events

2

last 24 months

Officers appointed

0

last 12 months

Officers resigned

0

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

• Turnover

  +122.1%

  £12,199,207 → £27,090,300

• Cash

  +31.6%

  £12,853,101 → £16,915,977

• Net assets

  -156.7%

  -£15,468,344 → -£39,711,371

• Employees

  0%

  230 → 230

• Operating profit

  -562.3%

  -£8,477,525 → -£56,150,754

• Profit before tax

  -201.1%

  £33,485,861 → -£33,864,052

• Wages

  +5.6%

  £16,324,698 → £17,241,045

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers